Ftse Mib
34.312,16
-0,19%
DAX
18.495,85
-0,56%
S&P 500
5.652,79
0,38%
NASDAQ
18.472,57
0,00%
Bitcoin
64.052,19
-1,23%
Registration Strip Icon for default Registrati gratuitamente per ottenere quotazioni in tempo reale, grafici interattivi, flusso di opzioni in tempo reale e altro ancora.
Registrati

Quotazioni in diretta

Non abbiamo trovato risultati per:
Assicurati di aver scritto correttamente o prova ad allargare la ricerca.

Più Attivi

Toplist

Sembra che tu non sia connesso.
Clicca il pulsante qui sotto per accedere e visualizzare la tua cronologia recente.

Registrati

Sei già registrato? Accedi

Pepperstone

Inizia Ora

Pepperstone
Home Investire Azioni U.S.A. NASDAQ Applied Therapeutics Inc (APLT) Applied Therapeutics Inc (APLT) Notizie

APLT

Applied Therapeutics (APLT)

HOME News News di Agenzia

News di Agenzia

Da:
 Ti mostriamo gli articoli più rilevanti per la tua ricerca:NASDAQ:APLT
DataOraFonteTitoloSimboloCompagnia
10/03/202212:33Edgar (US Regulatory)Annual Report (10-k)NASDAQ:APLTApplied Therapeutics Inc
01/03/202213:00GlobeNewswire Inc.Applied Therapeutics to Present at the Cowen and Barclays Investor ConferencesNASDAQ:APLTApplied Therapeutics Inc
28/02/202213:30GlobeNewswire Inc.Applied Therapeutics Supports 15th Annual Rare Disease DayNASDAQ:APLTApplied Therapeutics Inc
25/02/202223:27Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:APLTApplied Therapeutics Inc
15/02/202212:37Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:APLTApplied Therapeutics Inc
11/02/202222:27Edgar (US Regulatory)Amended Statement of Ownership (sc 13g/a)NASDAQ:APLTApplied Therapeutics Inc
10/02/202213:00GlobeNewswire Inc.Applied Therapeutics to Present at the 11th Annual SVB Leerink Global Healthcare ConferenceNASDAQ:APLTApplied Therapeutics Inc
28/01/202222:34Edgar (US Regulatory)Amended Statement of Beneficial Ownership (sc 13d/a)NASDAQ:APLTApplied Therapeutics Inc
26/01/202213:31Edgar (US Regulatory)Prospectus Filed Pursuant to Rule 424(b)(5) (424b5)NASDAQ:APLTApplied Therapeutics Inc
12/01/202200:44Edgar (US Regulatory)Amended Statement of Changes in Beneficial Ownership (4/a)NASDAQ:APLTApplied Therapeutics Inc
05/01/202203:06TipRanksApplied Therapeutics (APLT) was Downgraded to a Hold Rating at BarclaysNASDAQ:APLTApplied Therapeutics Inc
03/01/202216:48Dow Jones NewsApplied Therapeutics Shares Slide on Lead Candidate DelayNASDAQ:APLTApplied Therapeutics Inc
03/01/202214:01Dow Jones NewsApplied Therapeutics Delays Plans to Seek FDA Approval of AT-007NASDAQ:APLTApplied Therapeutics Inc
03/01/202213:00GlobeNewswire Inc.Applied Therapeutics Provides Regulatory Update on Galactosemia ProgramNASDAQ:APLTApplied Therapeutics Inc
16/12/202113:00GlobeNewswire Inc.Applied Therapeutics Announces Initiation of Registrational Phase 2/3 Study of AT-007 in SORD DeficiencyNASDAQ:APLTApplied Therapeutics Inc
18/11/202113:00GlobeNewswire Inc.Applied Therapeutics to Present at the 14th International Congress of Inborn Errors of MetabolismNASDAQ:APLTApplied Therapeutics Inc
12/11/202113:59Edgar (US Regulatory)Quarterly Report (10-q)NASDAQ:APLTApplied Therapeutics Inc
12/11/202113:00GlobeNewswire Inc.Applied Therapeutics Reports Third Quarter 2021 Financial ResultsNASDAQ:APLTApplied Therapeutics Inc
25/10/202113:00GlobeNewswire Inc.Applied Therapeutics Reports Biomarker Data from Pilot Trial of AT-007 in SORD DeficiencyNASDAQ:APLTApplied Therapeutics Inc
18/10/202113:00GlobeNewswire Inc.Applied Therapeutics Reports Additional Pediatric Biomarker Data from ACTION-Galactosemia KidsNASDAQ:APLTApplied Therapeutics Inc
09/09/202113:00GlobeNewswire Inc.Applied Therapeutics Reports Initial Pediatric Biomarker Data from ACTION-Galactosemia KidsNASDAQ:APLTApplied Therapeutics Inc
12/08/202113:00GlobeNewswire Inc.Applied Therapeutics Reports Second Quarter 2021 Financial ResultsNASDAQ:APLTApplied Therapeutics Inc
28/06/202113:00GlobeNewswire Inc.Applied Therapeutics Added to Russell Microcap® IndexNASDAQ:APLTApplied Therapeutics Inc
25/06/202118:05GlobeNewswire Inc.Applied Therapeutics Announces Presentation of Data on the Prevalence of Diabetic Cardiomyopathy at the 81st Scientific Sessi...NASDAQ:APLTApplied Therapeutics Inc
21/06/202113:00GlobeNewswire Inc.Applied Therapeutics to Present on Diabetic Cardiomyopathy and Prevalence of Disease at the 81st Scientific Sessions of the 2...NASDAQ:APLTApplied Therapeutics Inc
17/06/202113:32Dow Jones NewsApplied Therapeutics Gets FDA Fast-Track Designation for AT-007 in GalactosemiaNASDAQ:APLTApplied Therapeutics Inc
17/06/202113:00GlobeNewswire Inc.Applied Therapeutics Granted Fast Track Designation by FDA for AT-007 for GalactosemiaNASDAQ:APLTApplied Therapeutics Inc
01/06/202113:00GlobeNewswire Inc.Applied Therapeutics to Present at the Goldman Sachs 42nd Annual Global Healthcare ConferenceNASDAQ:APLTApplied Therapeutics Inc
19/05/202113:00GlobeNewswire Inc.Applied Therapeutics to Present at the UBS Global Healthcare Virtual ConferenceNASDAQ:APLTApplied Therapeutics Inc
11/05/202113:00GlobeNewswire Inc.Applied Therapeutics Reports First Quarter 2021 Financial ResultsNASDAQ:APLTApplied Therapeutics Inc
 Ti mostriamo gli articoli più rilevanti per la tua ricerca:NASDAQ:APLT

La tua Cronologia

BIT
UCG
Unicredit
BIT
ISP
Intesa Sanpaolo
BIT
ENEL
Enel
BIT
ENI
Eni
BIT
FBK
Finecobank
BIT
STLAM
Stellantis NV
BIT
RACE
Ferrari NV
BIT
PRY
Prysmian
BIT
BC
Brunello Cucinelli
BIT
BMPS
Banca Monte Dei Paschi D...
BIT
SPM
Saipem
BIT
BPE
Bper Banca
BIT
G
Generali
BIT
LDO
Leonardo
BIT
STMMI
ST Microelectronics
BIT
MONC
Moncler
Delayed Upgrade Clock
Per accedere al tempo reale push di Borsa è necessario registrarsi.

Il sito ADVFN Italia è stato realizzato ed è gestito da PRODESFIN su licenza di ADVFN PLC.

PER CONTATTI E PUBBLICITA' SUL SITO CLICCARE QUI

Accedendo ai servizi offerti da ADVFN, ne si accettano le condizioni generali Termini & Condizioni

ADVFN Network